Upstream / Downstream

Explore pathways related to this product.

Our U.S. Offices Will Be Closing Early

Our U.S. offices will be closing early on November 26th at 6:00 PM EST.

Questions?

Find answers on our FAQs page.

ANSWERS  

Visit PhosphoSitePlus®

PTM information and tools available.

LEARN MORE

Product Includes Quantity Applications Reactivity MW(kDa) Isotype
Phospho-mTOR (Ser2481) Antibody 2974 40 µl
Western Blotting
H M R Mk 289 Rabbit 
mTOR (7C10) Rabbit mAb 2983 40 µl
Western Blotting Immunohistochemistry Immunofluorescence Flow Cytometry
H M R Mk 289 Rabbit 
Raptor (24C12) Rabbit mAb 2280 40 µl
Western Blotting Immunoprecipitation
H M R Mk 150 Rabbit IgG
Rictor (53A2) Rabbit mAb 2114 40 µl
Western Blotting
H M R Mk 200 Rabbit IgG
GβL (86B8) Rabbit mAb 3274 40 µl
Western Blotting Immunoprecipitation
H M R Mk 37 Rabbit IgG
Phospho-mTOR (Ser2448) (D9C2) XP® Rabbit mAb 5536 40 µl
Western Blotting Immunoprecipitation Immunofluorescence
H M Mk 289 Rabbit IgG
Anti-rabbit IgG, HRP-linked Antibody 7074 100 µl
Western Blotting
All Goat 

Product Description

The mTOR Pathway Antibody Sampler Kit contains reagents to investigate the control of protein translation, cell growth, and proliferation through mTOR signaling within cells. The kit contains enough primary and secondary antibodies to perform four Western blot experiments per primary antibody.


Specificity / Sensitivity

Each total antibody in the mTOR Pathway Sampler Kit recognizes only its specific target. Each phospho-specific antibody detects the intended target only when phosphorylated at the indicated site.


Source / Purification

Polyclonal antibody is produced by immunizing animals with synthetic phosphopeptides corresponding to residues surrounding Ser2481 of human mTOR. Polyclonal antibodies are purified by protein A and peptide affinity chromatography. Monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Ser2448 of human mTOR, Gln1681 of human Rictor, Gln210 of human GβL and human Raptor.

The mammalian target of rapamycin (mTOR, FRAP, RAFT) is a Ser/Thr protein kinase (1-3) that functions as an ATP and amino acid sensor to balance nutrient availability and cell growth (4,5). When sufficient nutrients are available, mTOR responds to a phosphatidic acid-mediated signal to transmit a positive signal to p70 S6 kinase and participate in the inactivation of the eIF4E inhibitor, 4E-BP1 (6). These events result in the translation of specific mRNA subpopulations. mTOR is phosphorylated at Ser2448 via the PI3 kinase/Akt signaling pathway and autophosphorylated at Ser2481 (7,8). mTOR plays a key role in cell growth and homeostasis and may be abnormally regulated in tumors. For these reasons, mTOR is currently under investigation as a potential target for anti-cancer therapy (9).


The regulatory associated protein of mTOR (Raptor) interacts with mTOR to mediate mTOR signaling to downstream targets (10,11). Raptor binds to mTOR substrates, such as 4E-BP1 and p70 S6 kinase, through their TOR signaling (TOS) motifs and is required for mTOR-mediated substrate phosphorylation (12,13). Binding of the FKBP12-rapamycin complex to mTOR inhibits mTOR-raptor interaction, which suggests a mechanism for the inhibition of mTOR signaling by rapamycin (14). This mTOR-raptor interaction and its regulation by nutrients and/or rapamycin is dependent on a protein called GβL (15). GβL is part of the rapamycin-insensitive complex between mTOR and rictor (rapamycin-insensitive companion of mTOR) and may mediate rictor-mTOR signaling to PKCα and other downstream targets (16). The rictor-mTOR complex has been identified as the previously elusive PDK2 responsible for the phosphorylation of Akt/PKB at Ser473, which is required for PDK1 phosphorylation of Akt/PKB at Thr308 and full activation of Akt/PKB (17).


1.  Sabers, C.J. et al. (1995) J Biol Chem 270, 815-22.

2.  Brown, E.J. et al. (1994) Nature 369, 756-8.

3.  Sabatini, D.M. et al. (1994) Cell 78, 35-43.

4.  Dennis, P.B. et al. (2001) Science 294, 1102-5.

5.  Gingras, A.C. et al. (2001) Genes Dev. 15, 807-826.

6.  Fang, Y. et al. (2001) Science 294, 1942-5.

7.  Peterson, R.T. et al. (2000) J Biol Chem 275, 7416-23.

8.  Huang, S. and Houghton, P.J. (2003) Curr Opin Pharmacol 3, 371-7.

9.  Navé, B.T. et al. (1999) Biochem J 344 Pt 2, 427-31.

10.  Sarbassov, D.D. et al. (2004) Curr Biol 14, 1296-302.

11.  Sarbassov, D.D. et al. (2005) Science 307, 1098-101.

12.  Hara, K. et al. (2002) Cell 110, 177-189.

13.  Kim, D.H. et al. (2002) Cell 110, 163-175.

14.  Beugnet, A. et al. (2003) J. Biol. Chem. 278, 40717-40722.

15.  Nojima, H. et al. (2003) J. Biol. Chem. 278, 15461-15464.

16.  Oshiro, N. et al. (2004) Genes Cells 9, 359-366.

17.  Kim, D.H. et al. (2003) Mol. Cell 11, 895-904.


Entrez-Gene Id 64223, 2475, 57521, 253260
Swiss-Prot Acc. Q9BVC4, P42345, Q8N122, Q6R327


For Research Use Only. Not For Use In Diagnostic Procedures.
Cell Signaling Technology® is a trademark of Cell Signaling Technology, Inc.
U.S. Patent No. 5,675,063.